Blended palliative and survivorship care intervention (POISE) for patients with metastatic oncogene-driven non-small cell lung cancer: study protocol for a pilot randomised controlled trial.

ABSTRACT:

Introduction

Patients with metastatic oncogene-driven non-small cell lung cancer (NSCLC) are experiencing longer and uncertain trajectories of life-limiting illness due to advances in precision medicine. These advanced cancer survivors face new challenges related to living with uncertainty and desire more support to maximize their health and quality of life. Therefore, we developed a population-specific, blended palliative and survivorship care intervention to address the supportive care needs of patients recently diagnosed with advanced lung cancer and who are receiving targeted therapy for NSCLC with EGFR, ALK, ROS1 or RET driver mutations.

Methods and analysis

This study is a single-site, non-blinded pilot randomised controlled trial of an inte

SUBMITTER: Richard HA 

PROVIDER: S-EPMC12352232 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature